Literature DB >> 11883532

Rho GTPases in transformation and metastasis.

Aron B Jaffe1, Alan Hall.   

Abstract

During the development and progression of human cancer, cells undergo numerous changes in morphology, proliferation, and transcriptional profile. Over the past couple of decades there have been intense efforts to understand the molecular mechanisms involved, and members of the Ras superfamily of small GTPases have emerged as important players. Mutated versions of the Ras genes were first identified in human cancers some 20 years ago, but more recently, the Rho branch of the family has been receiving increased attention. In addition to the experimental evidence implicating Rho GTPase signaling in promoting malignant transformation, genetic analysis of human cancers has now revealed a few examples of direct alterations in the genes encoding regulators of Rho GTPases. In this review, we discuss the evidence implicating Rho GTPases in transformation and metastasis, as well as the progress made toward identifying their biochemical mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883532     DOI: 10.1016/s0065-230x(02)84003-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  87 in total

Review 1.  Janus-faces of NME-oncoprotein interactions.

Authors:  Nikolina Vlatković; Shie-Hong Chang; Mark T Boyd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-01       Impact factor: 3.000

2.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

3.  ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.

Authors:  Liangping Yuan; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald
Journal:  Clin Exp Metastasis       Date:  2010-06-06       Impact factor: 5.150

4.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

5.  Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling.

Authors:  Céline DerMardirossian; Gabriel Rocklin; Ji-Yeon Seo; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2006-08-30       Impact factor: 4.138

6.  Gef10--the third member of a Rho-specific guanine nucleotide exchange factor subfamily with unusual protein architecture.

Authors:  M Mohl; S Winkler; T Wieland; S Lutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07-29       Impact factor: 3.000

Review 7.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

8.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

9.  Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway.

Authors:  Young Joo Jeon; Joon Seok Choi; Jung Yun Lee; Kyung Ryun Yu; Seung Hyeun Ka; Yongcheol Cho; Eui-Ju Choi; Sung Hee Baek; Jae Hong Seol; Dongeun Park; Ok Sun Bang; Chin Ha Chung
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

10.  Extracellular beta-nicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement.

Authors:  Nagavedi S Umapathy; Evgeny A Zemskov; Joyce Gonzales; Boris A Gorshkov; Supriya Sridhar; Trinad Chakraborty; Rudolf Lucas; Alexander D Verin
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.